NEW YORK & NEWPORT, R.I.--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) and the Hope Funds for Cancer Research announced today that Jonathan Lewis, MD, PhD, Chief Executive and Medical Officer of ZIOPHARM, has been appointed to the Hope Funds’ newly formed Scientific Advisory Council, a permanent committee of the board. The Hope Funds for Cancer Research honors individuals or organizations that have made a significant impact on patient care, and funds highly innovative research addressing the most difficult-to-treat cancers. The Scientific Advisory Council will uphold the extraordinarily high standards of the Hope Funds Fellowship and make recommendations on its prospective awardees.
